Eli Lilly has warned of high levels of an impurity in certain compounded versions of its blockbuster glucagon-like peptide-1 receptor agonist (GLP-1RA) tirzepatide. Lilly issued the public warning ...

Pharmaceutical company Lilly has issued a warning about potential health risks associated with compounded tirzepatide mixed with vitamin B12. The company's testing revealed significant levels of an ...